vs
NATIONAL BEVERAGE CORP（FIZZ）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
NATIONAL BEVERAGE CORP的季度营收约是Ultragenyx Pharmaceutical Inc.的1.4倍（$288.3M vs $207.3M），NATIONAL BEVERAGE CORP净利率更高（16.1% vs -62.0%，领先78.1%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -1.0%），NATIONAL BEVERAGE CORP自由现金流更多（$19.9M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 3.3%）
国家饮料公司是美国的饮料开发、生产及分销企业，总部位于佛罗里达州劳德代尔堡，主打风味软饮产品，旗下知名品牌包括LaCroix气泡水、Shasta和Faygo等，产品覆盖美国多地消费市场。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
FIZZ vs RARE — 直观对比
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $288.3M | $207.3M |
| 净利润 | $46.4M | $-128.6M |
| 毛利率 | 37.9% | — |
| 营业利润率 | 20.1% | -54.7% |
| 净利率 | 16.1% | -62.0% |
| 营收同比 | -1.0% | 25.9% |
| 净利润同比 | 1.6% | 3.5% |
| 每股收益（稀释后） | $0.49 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $288.3M | $207.3M | ||
| Q3 25 | $330.5M | $159.9M | ||
| Q2 25 | $313.6M | $166.5M | ||
| Q1 25 | $267.1M | $139.3M | ||
| Q4 24 | $291.2M | $164.6M | ||
| Q3 24 | $329.5M | $139.5M | ||
| Q2 24 | $297.3M | $147.0M | ||
| Q1 24 | $270.1M | $108.8M |
| Q4 25 | $46.4M | $-128.6M | ||
| Q3 25 | $55.8M | $-180.4M | ||
| Q2 25 | $44.8M | $-115.0M | ||
| Q1 25 | $39.6M | $-151.1M | ||
| Q4 24 | $45.6M | $-133.2M | ||
| Q3 24 | $56.8M | $-133.5M | ||
| Q2 24 | $43.7M | $-131.6M | ||
| Q1 24 | $39.6M | $-170.7M |
| Q4 25 | 37.9% | — | ||
| Q3 25 | 38.0% | — | ||
| Q2 25 | 36.1% | — | ||
| Q1 25 | 37.1% | — | ||
| Q4 24 | 37.6% | — | ||
| Q3 24 | 37.2% | — | ||
| Q2 24 | 36.7% | — | ||
| Q1 24 | 35.9% | — |
| Q4 25 | 20.1% | -54.7% | ||
| Q3 25 | 21.4% | -106.9% | ||
| Q2 25 | 18.3% | -64.8% | ||
| Q1 25 | 18.9% | -102.6% | ||
| Q4 24 | 19.9% | -74.3% | ||
| Q3 24 | 21.1% | -94.6% | ||
| Q2 24 | 17.8% | -79.1% | ||
| Q1 24 | 17.8% | -151.9% |
| Q4 25 | 16.1% | -62.0% | ||
| Q3 25 | 16.9% | -112.8% | ||
| Q2 25 | 14.3% | -69.0% | ||
| Q1 25 | 14.8% | -108.5% | ||
| Q4 24 | 15.7% | -80.9% | ||
| Q3 24 | 17.2% | -95.7% | ||
| Q2 24 | 14.7% | -89.5% | ||
| Q1 24 | 14.7% | -156.8% |
| Q4 25 | $0.49 | $-1.28 | ||
| Q3 25 | $0.60 | $-1.81 | ||
| Q2 25 | $0.47 | $-1.17 | ||
| Q1 25 | $0.42 | $-1.57 | ||
| Q4 24 | $0.49 | $-1.34 | ||
| Q3 24 | $0.61 | $-1.40 | ||
| Q2 24 | $-52.00 | $-1.52 | ||
| Q1 24 | $0.42 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $269.3M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $551.3M | $-80.0M |
| 总资产 | $749.0M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $269.3M | $421.0M | ||
| Q3 25 | $249.8M | $202.5M | ||
| Q2 25 | $193.8M | $176.3M | ||
| Q1 25 | $149.2M | $127.1M | ||
| Q4 24 | $112.8M | $174.0M | ||
| Q3 24 | $77.0M | $150.6M | ||
| Q2 24 | $327.0M | $480.7M | ||
| Q1 24 | $277.0M | $112.3M |
| Q4 25 | $551.3M | $-80.0M | ||
| Q3 25 | $504.1M | $9.2M | ||
| Q2 25 | $444.0M | $151.3M | ||
| Q1 25 | $400.2M | $144.2M | ||
| Q4 24 | $360.1M | $255.0M | ||
| Q3 24 | $306.6M | $346.8M | ||
| Q2 24 | $559.5M | $432.4M | ||
| Q1 24 | $510.2M | $140.3M |
| Q4 25 | $749.0M | $1.5B | ||
| Q3 25 | $737.8M | $1.2B | ||
| Q2 25 | $672.9M | $1.3B | ||
| Q1 25 | $594.0M | $1.3B | ||
| Q4 24 | $557.4M | $1.5B | ||
| Q3 24 | $522.6M | $1.5B | ||
| Q2 24 | $770.2M | $1.6B | ||
| Q1 24 | $719.9M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $25.7M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $19.9M | $-100.8M |
| 自由现金流率自由现金流/营收 | 6.9% | -48.6% |
| 资本支出强度资本支出/营收 | 2.0% | 0.5% |
| 现金转化率经营现金流/净利润 | 0.55× | — |
| 过去12个月自由现金流最近4个季度 | $156.8M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $25.7M | $-99.8M | ||
| Q3 25 | $59.1M | $-91.4M | ||
| Q2 25 | $60.1M | $-108.3M | ||
| Q1 25 | $46.5M | $-166.5M | ||
| Q4 24 | $42.6M | $-79.3M | ||
| Q3 24 | $57.5M | $-67.0M | ||
| Q2 24 | $60.4M | $-77.0M | ||
| Q1 24 | $35.4M | $-190.7M |
| Q4 25 | $19.9M | $-100.8M | ||
| Q3 25 | $56.0M | $-92.7M | ||
| Q2 25 | $44.6M | $-110.7M | ||
| Q1 25 | $36.3M | $-167.8M | ||
| Q4 24 | $35.7M | $-79.5M | ||
| Q3 24 | $53.8M | $-68.6M | ||
| Q2 24 | $49.6M | $-79.0M | ||
| Q1 24 | $28.7M | $-193.9M |
| Q4 25 | 6.9% | -48.6% | ||
| Q3 25 | 16.9% | -58.0% | ||
| Q2 25 | 14.2% | -66.5% | ||
| Q1 25 | 13.6% | -120.5% | ||
| Q4 24 | 12.3% | -48.3% | ||
| Q3 24 | 16.3% | -49.2% | ||
| Q2 24 | 16.7% | -53.7% | ||
| Q1 24 | 10.6% | -178.2% |
| Q4 25 | 2.0% | 0.5% | ||
| Q3 25 | 0.9% | 0.8% | ||
| Q2 25 | 4.9% | 1.5% | ||
| Q1 25 | 3.8% | 1.0% | ||
| Q4 24 | 2.4% | 0.1% | ||
| Q3 24 | 1.1% | 1.2% | ||
| Q2 24 | 3.6% | 1.4% | ||
| Q1 24 | 2.5% | 3.0% |
| Q4 25 | 0.55× | — | ||
| Q3 25 | 1.06× | — | ||
| Q2 25 | 1.34× | — | ||
| Q1 25 | 1.17× | — | ||
| Q4 24 | 0.93× | — | ||
| Q3 24 | 1.01× | — | ||
| Q2 24 | 1.38× | — | ||
| Q1 24 | 0.89× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FIZZ
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
